Karl Collins
Podiatrist · Florissant, MONPI 1376587535
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $197 and has fallen 60.8% since, to $77 in 2025. That places this record below the midpoint for podiatrist clinicians in MO, where the typical reported total is $1,070.
Across 39 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$160
- Medtronic$66
- Vaporox, Inc.$65
- Sandoz$59
- Elite Orthopedics, LLC$44
- Kowa Pharmaceuticals America, Inc.$43
- plus $325 from 14 others
What the payments were for
- Food & beverage$761100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 7 | $160 |
| Medtronic | 2 | $66 |
| Vaporox, Inc. | 1 | $65 |
| Sandoz | 4 | $59 |
| Elite Orthopedics, LLC | 2 | $44 |
| Kowa Pharmaceuticals America, Inc. | 3 | $43 |
| Organogenesis Inc. | 3 | $42 |
| Axogen | 2 | $40 |
| Smith+Nephew | 2 | $30 |
| Paratek Pharmaceuticals, Inc. | 2 | $27 |
| Tactile Systems Technology Inc | 2 | $26 |
| Kerecis Limited | 1 | $24 |
| Aroa Biosurgery Incorporated | 1 | $21 |
| Arthrosurface Incorporated | 1 | $19 |
| Nevro Corp. | 1 | $19 |
| Amgen | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $16 |
| Orthofix Medical, Inc. | 1 | $8 |
How this compares
$761 in reported general payments places this provider in the 45th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tavaborole | 26 | $8,433 |
| Gentamicin Sulfate | 56 | $1,476 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 30 | $1,430 |
| Econazole Nitrate | 39 | $524 |
| Cephalexin | 16 | $128 |
| Methylprednisolone | 12 | $85 |
| Mupirocin | 16 | $66 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Florissant
- Zachary NewlandFlorissant$4K
- Brian BroadheadFlorissant$3K
- William DukeJefferson City$54K
- Kiera Benge-SheaSaint Louis$28K
- Thomas BoldryLiberty$19K
- Ryan FrankIndependence$15K
- Neil ErmitanoSaint Louis$14K
- John HarnessOverland$14K
- Brittany StaplesCreve Coeur$13K
- Daniel NarowitzSaint Louis$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.